LOGIN
The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty
March 2025
The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty: A Multicenter Randomized Clinical Trial.
J Bone Joint Surg Am. 2020 Nov 4;102(21):1883-1890.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred seventy-five patients undergoing revision total hip arthroplasty were randomized to receive one of four tranexamic acid (TXA) regimens: a single 1-g intravenous (IV) dose (n=43), a double 1-g IV dose (n=40), a combined 1-g IV and 1-g topical dose (n=46), or three oral doses totaling 1,950 mg (n=46). The primary outcome was the reduction in postoperative hemoglobin levels. Secondary out...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.